Jump to content
Knowledge Hub

News Archive

FDA - Roundup, 30th August 2024

5th September 2024

An at-a-glance summary of news from around the agency

Read More+

FDA - Warning Letter to Italian Company

5th September 2024

The warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. 3. Your firm failed to ensure that laboratory records included complete data derived from all tests necessary to ensure compliance with established specifications and standards (21 CFR 211.194(a)).

Read More+

MHRA - Advertising Investigations

5th September 2024

Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.

Read More+

MHRA - Appointments of four MHRA Non-Executive Directors extended until 31 August 2025

5th September 2024

Extended from 1 September 2024 until 31 August 2025.

Read More+

MHRA - Consultation on Statutory Fees

5th September 2024

Proposals on ongoing cost recovery

Read More+

MHRA - Pharmacovigilance following agreement of the Windsor Framework

5th September 2024

MHRA have published information on the implementation of changes to pharmacovigilance for medicines authorised in the UK following the agreement of the Windsor Framework.

Read More+

WHO - Guidance aims to curb antibiotic pollution from manufacturing

5th September 2024

New global guidance released

Read More+

MHRA - Performance Metrics Published

16th August 2024

MHRA performance metrics for clinical trials and established medicines assessment.

Read More+

EMA - Veterinary Scientific Guidance Update - Adopted and Draft Guidance

14th August 2024

New adopted and draft guidelines relating to Veterinary Products

Read More+

MHRA - Medicines Pipeline data

14th August 2024

New Guidance Published

Read More+
« Previous | Page 2 of 98 | Next »

Share

Virtual Event Platform